Parkinson's patients face increased depression, independence issues due to poor sleep
A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...
Jupiter Neurosciences, Inc.: Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based ...
UC San Francisco1d
How a UCSF Scientist Helped Ban a Chemical Connected to Parkinson’s
A new EPA ban on TCE, a common industrial cleaning agent and contaminant, begins this year. UCSF’s Samuel Goldman, who led groundbreaking research to link TCE to Parkinson’s Disease, talks about the ...
AI model identifies potential risk genes for Parkinson's disease
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Multiple Sclerosis News Today2d
Enigma to use Neuraly’s PET tracer to monitor MS neuroinflammation
The agreement will allow Enigma to use its PET imaging tracer PMI04 to visualize microglia activity in neurodegenerative ...